One shot to shield against malaria? new antibody trial aims to protect women
NCT ID NCT07060508
Summary
This study is testing if a single injection of an antibody called L9LS can safely prevent malaria infection. It will involve 290 adults, primarily women of childbearing age in Mali, who will receive either the antibody or a placebo. Researchers will monitor participants for six months through the malaria season to see if the injection reduces infections compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faladje MRTC Clinic
RECRUITINGFaladié, Koulikoro, Mali
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kalifabougou MRTC Clinic
RECRUITINGKalifabougou, Koulikoro, Mali
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Torodo MRTC Clinic
RECRUITINGTorodo, Koulikoro, Mali
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.